- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2211-8039
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
EZH2: novel therapeutic target for human cancer ; volume:4 ; number:1 ; day:12 ; month:2 ; year:2014 ; pages:1-6 ; date:3.2014
Biomedicine ; 4, Heft 1 (12.2.2014), 1-6, 3.2014
- Creator
-
Li, Long-Yuan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.7603/s40681-014-0001-6
- URN
-
urn:nbn:de:101:1-2021082219332266488083
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Long-Yuan
- SpringerLink (Online service)
Other Objects (12)
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
EZH2: a novel target for cancer treatment
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
Novel Therapeutic Targets in Axial Spondyloarthritis
Regulation of TRAIL expression by PRAME and EZH2 as potential therapeutic target against solid tumors
SUMOylation in glioblastoma : a novel therapeutic target
PHGDH: a novel therapeutic target in cancer
Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets
Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS mutated human pulmonary adenocarcinoma
FXYD6: a novel therapeutic target toward hepatocellular carcinoma
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
EZH2: a novel target for cancer treatment
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
Novel Therapeutic Targets in Axial Spondyloarthritis
Regulation of TRAIL expression by PRAME and EZH2 as potential therapeutic target against solid tumors
SUMOylation in glioblastoma : a novel therapeutic target
PHGDH: a novel therapeutic target in cancer
Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets
Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS mutated human pulmonary adenocarcinoma
FXYD6: a novel therapeutic target toward hepatocellular carcinoma
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
EZH2: a novel target for cancer treatment
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
Novel Therapeutic Targets in Axial Spondyloarthritis
Regulation of TRAIL expression by PRAME and EZH2 as potential therapeutic target against solid tumors
SUMOylation in glioblastoma : a novel therapeutic target
PHGDH: a novel therapeutic target in cancer
Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets
Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS mutated human pulmonary adenocarcinoma
FXYD6: a novel therapeutic target toward hepatocellular carcinoma